Rhythm Biosciences Ltd. launched a new genetype colorectal cancer risk assessment clinical test that incorporates clinical ...
Researchers investigated whether the time interval between a positive FIT result and follow-up colonoscopy is linked to risk for CRC.
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Exelixis, Inc. and Natera , a global leader in cell-free DNA and precision medicine, today announced their collaboration on the planned Exelixis-sponsored STELLAR-316 trial. This randomized phase 3 ...
A blood-based liquid biopsy combining cell-free and exosome-bound microRNAs detected early-onset colorectal cancer (CRC) with strong overall diagnostic performance, high sensitivity for early stages, ...
Parts Cleaner and Degreaser is put to the test in this video featuring @CRCAutoUS. Discover its performance and effectiveness in automotive cleaning applications. The video covers detailed evaluations ...
Get the latest news, expert insights, exclusive resources, and strategies from industry leaders – all for free.